HSDT vs. CUTR, QTI, ICU, PAVM, PSTV, STRR, CTCX, NUWE, CHEK, and TNON
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Cutera (CUTR), QT Imaging (QTI), SeaStar Medical (ICU), PAVmed (PAVM), Plus Therapeutics (PSTV), Star Equity (STRR), Carmell (CTCX), Nuwellis (NUWE), Check-Cap (CHEK), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry.
Helius Medical Technologies vs.
Helius Medical Technologies (NASDAQ:HSDT) and Cutera (NASDAQ:CUTR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, community ranking, valuation, institutional ownership, media sentiment, profitability and dividends.
Helius Medical Technologies currently has a consensus target price of $24.00, indicating a potential upside of 4,287.57%. Cutera has a consensus target price of $3.00, indicating a potential upside of 523.83%. Given Helius Medical Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Helius Medical Technologies is more favorable than Cutera.
Cutera received 316 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. Likewise, 63.28% of users gave Cutera an outperform vote while only 55.56% of users gave Helius Medical Technologies an outperform vote.
In the previous week, Cutera had 1 more articles in the media than Helius Medical Technologies. MarketBeat recorded 2 mentions for Cutera and 1 mentions for Helius Medical Technologies. Helius Medical Technologies' average media sentiment score of 1.00 beat Cutera's score of 0.00 indicating that Helius Medical Technologies is being referred to more favorably in the media.
18.6% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 90.7% of Cutera shares are held by institutional investors. 5.1% of Helius Medical Technologies shares are held by insiders. Comparatively, 0.4% of Cutera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Helius Medical Technologies has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, Cutera has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.
Cutera has a net margin of -84.86% compared to Helius Medical Technologies' net margin of -1,764.74%. Cutera's return on equity of 0.00% beat Helius Medical Technologies' return on equity.
Helius Medical Technologies has higher earnings, but lower revenue than Cutera. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.
Summary
Cutera beats Helius Medical Technologies on 9 of the 17 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:HSDT) was last updated on 2/18/2025 by MarketBeat.com Staff
